MedPath
Found 549753 clinical trials
Sort by:

Impact of Pleural Manometry on the Assessment and Treatment of Malignant Pleural Effusion: A Pilot Clinical Trial

Not Applicable
Recruiting
Conditions
Malignant Pleural Effusions (Mpe)
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Target Recruit Count
95
Registration Number
NCT07120867
Locations
🇪🇸

Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

A Clinical Study Evaluating HAIC Combined With Iparomlimab and Tuvonralimab Injection Plus Bevacizumab in Patients With Initially Potentially Resectable Hepatocellular Carcinoma (ITBHaic Study)

Not Applicable
Not yet recruiting
Conditions
HCC
Interventions
Drug: lparomlimab and Tuvonralimab Injection in Combination with HAIC and bevacizumab
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
34
Registration Number
NCT07119931

Does Hip Strength Impact Active Females Rate of Pelvic Floor Dysfunction? The Primary Goal of This Research is to Collect Data on Hip Strength for Active Females and Assess if There is a Relationship Between Hip Strength and Pelvic Floor Dysfunction (PFD).

Completed
Conditions
Pelvic Floor Muscle Weakness
Pelvic Floor Disorder
Pelvic Pain
Hip Strength
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
George Fox University
Target Recruit Count
55
Registration Number
NCT07119476
Locations
🇺🇸

George Fox University Medical Sciences Building, Newberg, Oregon, United States

Effects of 20-week Mat-Pilates & Dual-Task Training on Strength, Balance, Cognition, and Fall Risk in Older Adults

Not Applicable
Active, not recruiting
Conditions
Healthy People Programs
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
Universidade do Porto
Target Recruit Count
67
Registration Number
NCT07119762
Locations
🇵🇹

CIAFEL, Porto, Portugal

Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.

Not Applicable
Recruiting
Conditions
Glioblastoma
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
Jules Bordet Institute
Target Recruit Count
50
Registration Number
NCT07119294
Locations
🇧🇪

Institut Jules Bordet, Brussels, Belgium

COMPARISON OF CLINICAL EFFECTS OF LISTERINE AND CHLORHEXIDINE MOUTH WASH IN PATIENTS UNDERGOING FIXED ORTHODONTIC TREATMENT

Not Applicable
Recruiting
Conditions
Gingivitis
Dental Plaque
Interventions
Drug: Listerine Mouthwash Product
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
Khyber Medical University Peshawar
Target Recruit Count
60
Registration Number
NCT07119840
Locations
🇵🇰

Saidu College of Dentistry, Swāt, KPK, Pakistan

Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC

Not Applicable
Not yet recruiting
Conditions
Lung Cancer (NSCLC)
Interventions
Drug: Tislelizumab 400 mg iv, q6w, for up to 1 year for pts in intervention group
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Target Recruit Count
108
Registration Number
NCT07120282

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Not Applicable
Not yet recruiting
Conditions
Locoregionally Recurrent Hormone-receptor Positive Breast Cancer
Metastatic Hormone Receptor Positive Breast Cancer
Interventions
Drug: 68Ga-R11228
Drug: 177Lu-R11228
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
Radionetics Oncology
Target Recruit Count
62
Registration Number
NCT07121244

Post-operative Changes Study

Recruiting
Conditions
Post-operative Functional Decline
Severe Neurological Impairment
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
University of British Columbia
Target Recruit Count
17
Registration Number
NCT07121660
Locations
🇨🇦

BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada

Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.

Recruiting
Conditions
Cervical Cancer
Hysterectomy
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
Medical University of Silesia
Target Recruit Count
300
Registration Number
NCT07120529
Locations
🇵🇱

Uniwersyteckie Centrum Onkologii, Uniwersytecki Szpital Kliniczny w Białymstoku, Białystok, Poland

🇵🇱

Department of Gynaecology, Obstetrics and Gynaecological Oncology, University Clinical Centre, Medical University of Silesia, Katowice, Poland

🇵🇱

Klinika Ginekologii, Świętokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakład Opieki Zdrowotnej, Kielce, Poland

and more 2 locations

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.